Converting enzyme activity in normotensive rabbits during periods of rapid plasma volume expansion and depletion, 1977 by Morris, Glenda F. (Author) & Myers, Joseph B. (Degree supervisor)
CONVERTING ENZYME ACTIVITY IN NORMOTpiSIVE RABBITS
DURING PERIODS OF RAPID PLASMA VOLUME EXPANSION
AND DEPICTION
A THESIS
SUBMITTED TO THE FACULTY OF ATLANTA UNIVERSITY
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS











MORRIS, GLENDA FAE B.A., Fisk University, 1974
Converting Enzyme Activity in Normotensive Rabbits During Periods of Rapid
Plasma Volume Expansion and Depletion
Advisor: Dr. Joseph B. tfyers
Master of Science degree conferred August 5, 1977
Thesis dated August, 1977
The objective of this investigation was to determine converting
enzyme activity (CEA) in the lungs and the plasma of conscious rabbits
during periods of rapid plasma volume expansion and depletion. Blood
pressure changes and plasma renin activity (FRA) were measured also for
possible correlations with CEA.
Fifteen male New Zealand white rabbits (4-5 kg) wdre divided into 3
groups, controls, plasma voltmte expansion (FVE) and plasma volume depletion
(FVD). Direct blood pressure was monitored via a carotid cannula for a
period of 20 min in order to establish normal levels. The plasma volume
of 5 conscious rabbits was expanded by Infusing a protein-buffered saline
solution at a rate of 1.7 ml/mln for 15 min. Plasma voltmte expansion
caused a 177. Increase in blood pressure with a simultaneous decrease in
PRA. When 5 conscious rabbits were hemorrhaged at a rate of 1.7 ml/mln for
15 min a 24% decrease in blood pressure was seen while PRA Increased
significantly. Initial and final PRAs for PVE were 16.0 and 7.0 ng/ml/hr
and 14.8 and 20,0 ng/ml/hr for PVD, respectively.
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Rapid plasma volume expansion and depletion had no significant effect
on plasma CEA. Initial values were, controls 5.12 + 2.67, PVD 5.81 + 3.01
and PVE 4.67 + 2.09 ng/ml/hr. Final values were 3.82 + 1.99 for controls,
1.98 + 0,82 and 3,03 + 1,99 ng/ml/hr for PVD and PVE, respectively
The final enzyme preparation for the lung converting enzyme resulted
In a significant Increase In specific activity In all 3 groups of tissue.
Partial purification resulted in a 65-fold Increase In specific activity in
the control group. The PVD group showed the greatest Increase In specific
activity (72-fold), while the PVE had the lowest increase (37-fold).
These findings suggest that the lung converting enzyme is liiq)ortant
during periods of rapid plasma volume depletion, and that the lung is the
major source of the converting enzyme. No direct correlations between PBA
and plasma CEA were seen, but lung CEA Increased simultaneously with PRA
during plasma volttme depletion.
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The converting enzyme is a conq>onent of the renln-anglotensln
system, which Is believed to regulate sodium and potassium balance and
blood pressure-blood volume homeostasis. The activity of this system Is
Interrelated with neurovascular, humoral, and local cellular mechanisms
(1). Renin, a proteolytic enzyme secreted by the juxtaglomerular cells of
the afferent arteriole In the kidney, reacts with Its substrate, anglo-
tenslnogen, to produce the decapeptlde, angiotensin 1 (A 1). A 1 Is
thought to be an Inactive precursor synthesized In the liver. The con¬
verting enzyme then catalyzes the release of the dlpeptlde, hlstldyl-
leuclne, from the COOH-termlnus of A I to yield a pressor octapeptlde,
angiotensin 11 - A II (2). A II Is the vasoactive agent of the renln-
anglotensln system (3), and has three liiq>ortant physiological actions: 1)
It constricts the arterioles and Is by weight the most potent pressor
substance known, 2) It acts Immediately and directly on the kidney to cause
sodium retention with lower dosages and natrluresls with larger amounts,
and 3) It acts on the adrenal cortex to evoke a prompt and sustained
Increase In aldosterone secretion (1). The circulating A 11 Is then
degraded Into Inactive fragments by anglotenslnases found In the plasma.
The A I converting enzyme was discovered by Skeggs and his co¬
workers (1,A) when they found an enzyme In horse plasma that converted A I
to A 11. Around the same time Helmer (3,5) also noticed that his angio¬
tensin preparation was activated by a factor In the plasma.
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There are many sources of the converting enzyme and It has been
purified to various degrees. In vivo experiments Indicate that most of the
conversion of A 1 occurs In the lung, with some activity In the plasma and
kidney (6-9).
In order to evaluate the conqponents of the cardiovascular regulatory
mechanism, several Investigators have measured factors which are known to
assist the cardiovascular system In the process of autoregulatlon. Vender
and others (10) have discussed the effects of volume expansion and hemor¬
rhage on renal hormonal, sodium and potassium levels. High renin levels
have been found during decreased blood volume along with Increased sodium
retention (11,12). Volume expansion tends to Induce fluid balance problems
similar to those seen during salt loading conditions; high sodltim levels
may suppress the release of renin (12,13). Studies by Hodge et al. (11)
have shown that the renln-anglotensln system Is of Importance In both long
and short term homeostatic responses to changes In blood volume.
The renln-anglotensln system Is of physiological Importance to man
and the converting enzyme Is required In the renln-anglotensln system.
Therefore, the purpose of this Investigation was: 1) to develop an
adequate and reliable procedure for measuring converting enzyme activity;
2) to compare the plasma and lung converting enzyme activities In rabbits
subjected to two experimental alterations In blood volinne; plasma volume
expansion and plasma volume depletion; 3) to partially purify the lung
converting enzyme; and 4) to correlate the plasma converting enzyme
activity with the plasma renin activity In two experimental systems.
CHAPTER II
REVIEW OF LITERATURE
The investigations of Skeggs et al. (2,4) and Helmer (3,5) were
firsts in the discovery and description of the angiotensin I (A I) con¬
verting enz3nne. Skeggs et al. (2) partially purified the enzyme from horse
plasma and showed that it had a high degree of specificity, cleaving A 1
between amino acid eight, phenylalanine, and amino acid nine, histidine.
After the original observations of Skeggs and Helmer, there were few
significant contributions available in the literature as to the nature of
the converting enzyme. The biochemical study of the enzyme was hindered by
the tedious and time-consuming biological assays that were developed, using
the perfused kidney (2), the rat uterus (14), and the rabbit aortic strip
(5,15). Other assay systems have since been developed for measuring con¬
verting enzyme activity: a radiometric technique (16), a spectrophotometrlc
technique (17), a fluorlmetric assay (18), and an automated chemical assay
(19,20). Radloimnunoassays for angiotensin II (A II) have been described by
several investigators (21-27). There have been differences in the methods
of producing antibodies in the radloinmunoassay and differences in the way
in which antibody-bound angiotensin is separated from the free angiotensin.
The recent Interest in the converting enzyme was stimulated by the
availability of synthetic A I and the discovery by Ng et al. (28) that the
conversion of circulating A I into A II took place in the lungs rather than
in the blood. Conversion of A I has now been confirmed in the lungs of the
guinea pig, hog, cat, rat, dog, rabbit, and man (9,29-32).
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The converting enzyme has been found in various tissues since It was
first detected In blood (13,33,34). Kiese sources Include the brain,
liver, heart, kidney, small Intestine, and diaphragm. The lung contains
far more converting enzymes than any other tissue Investigated (28,34).
The purification, biochemical and physical stxidles of the enzyme
have varied with each Investigator. This may have been due to the Isolation
procedure used, the species differences of the enzyme sources, and the assay
procedure applied. The enzyme requires chloride Ions and Is Inhibited by
EDTA (2). In vitro Inhibitors of the enzyme are metal-blndlng agents such
as 0-phenanthrollne (35). Snake venom peptides have been found to Inhibit
the enzyme In vitro and In vivo (36-38). Products of the enzymatic
cleavage of bradyklnln (a vasodilator) and A I, such as Fhe-Arg and Hls-Leu
dlpeptldes, respectively, also Inhibit the enzyme (39).
Erdos et al. (40) extracted the enzyme from the microsomal fraction
of the kidney, first as klnlnase II, and then as converting enzyme from the
lung (41). They later purified It from plasma (40-42). Eliseeva et al.
(43) purified a renal enzyme and believed It to be Identical to a
"carboxycathepsln." Cushman and co-workers (44) purified the enzyme from
rabbit lung. It has also been purified from hog lung (17,20).
The localization of the lung enzyme has been studied by several
Investigators such as Caldwell et al. (45) and they found that the enzyme
was localized In vascular endothelial cells. They suggested, therefore,
that In most organs the enzyme Is directly accessible to circulating blood.
Ryan et al. (46) Indicated that the pulmonary converting enzysie may be
concentrated on the luminal surface of the endothelial cells. Sanders et
al. (47) found that the enzyme In rabbit lung was located subcellularly
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and suggested that the plasma membrane Is the site of enzyme activity.
Soffer and co-workers (48) purified the enz3rme directly from a particulate
fraction of rabbit pulmonary particles and proposed that membrane-bound
activity was responsible for the generation of A II.
Hodge and associates (11) were concerned with the effects of blood
volume alterations on the concentration of circulating angiotensin. They
found that Increasing the blood volume caused a fall In angiotensin con¬
centration which was not due to dilution of the blood. When the blood
volume was reduced, a rise In the concentration of circulating angiotensin
was seen.
As the A I converting enzyme cleaves A I to A II, It also Inactivates
bradyklnln, a vasodilator, idien prepared In a hl^ly purified form (11,41-
44,48,51). Since It occurs In many tissues. It probably has multiple
functions (39). The converting enz3nBe has been found In higher concentra¬
tions In pulmonary arteries than In any other vessels (52). The enzyme may
be liiq;>ortant In regulating the systemic blood pressure by metabolizing
circulating vasoactive peptides by releasing A II; by Inactivating brady¬




Fifteen male New Zealand white rabbits, weighing 4-5 kg were main¬
tained on a normal diet of Purina laboratory chow. Water was given ad
libitum. Carotid pressure was recorded on a desk model physlograph (DMP-
4B, Narco-Bio Systems, Inc., Houston, Texas), coupled to a strain gage
preanq>llfler (Type 312, Narco-Bio Systems). Human angiotensin I (5-Ileu-AI)
used as the substrate for the estimation of converting enzyme activity was
125obtained from Beckman Bioproducts, Palo Alto, California. I angio¬
tensin I radioimmunoassay (RIA) kits and Rlafluor were obtained from New
England Nuclear (Boston, Massachusetts). All counts were made on a Beckman
LS-230 liquid scintillation coixnter (Beckman Instruments, Atlanta, Georgia).
Methods of Procedure
Surgical Procedure
The rabbits were fasted 24 hr prior to surgery. All animals were
weighed and anesthetized via the marginal ear vein with sodium pento¬
barbital, (Nembutal) 35 mg/kg body weight. In all animals the left common
carotid artery was cannulated with polyethylene tiiblng (P.E. 50) in order
to monitor direct blood pressure throughout the experimental procedure.
The right external Jugular vein was cannulated using Dow-Cornlng medical
grade silastic tubing (#602-205, .04 in l.D. x .085 in O.D.). The jugular
vein was used for rapid plasma voltone expansion or depletion in the
experimental groups of animals. The animals were then allowed to recover
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from the anesthesia. Initial blood saiqples were collected via the arterial
cannula for studies on plasma converting enzyme activity (CEA) and plasma
renin activity (PRA). Blood sauries for CEA determinations were collected
in chilled test tubes containing 0.5 ml of 3.8% sodium citrate. Samples
for PRA determinations were collected in dillled tubes, each containing
10.5 mg dlsodltim EDTA. The samples were frozen until time for the specific
assays to be done. Hematocrits were taken before and after the surgery via
the marginal ear vein.
Control Group
The blood pressure was monitored for a period of 20 min in 5
conscious rabbits, or until a stable pressure was obtained. After bipod
pressure stabilization, two final blood samples were collected from each
animal for CEA cmd PRA studies.
Plasma Volume Escpansion Group
After maintaining a stable pressure, the plasma volume of 5
conscious rabbits was expanded by Infusing a protein-buffered sterile
saline solution (0.9%) into the external jugular vein. The solution con¬
tained 4-6 mEq/1 potassium and 10 g/200 ml of human serum protein albumin
(Lot #400601; Cal-Blochem, San Diego, California). Infusions were
performed at a rate of 1.7 mg/mln for 15 min. Changes in blood pressure
were recorded throughout the infusion period. Final samples were taken
after the 15 min period for studies on CEA and PRA. A total of 25 ml was
Infused
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Plasma Voltme Depleted Group
Five conscious rabbits were hemorrhaged at a rate of 1.7 ml/mln for
15 min with simultaneous blood pressure monitoring. A total of 25 ml of
blood was removed during the hemorrhage. Final blood samples were then
collected from each animal.
Plasma Renin Assays
Plasma renin activity was determined by using the protocol of New
England Nuclear for the A I RIA kit. Samples were done In duplicate
and were counted for 5 min each In a liquid scintillation counter.
Converting Enzyme Sources
In addition to the plasma samples, the lungs were used as the source
of the converting enzyme. After termination of the experiment, the animals
were sacrificed by air embolism via the external jugular vein. Hie lungs,
hearts, and kidneys were removed and placed In a chilled physiological
saline solution and perfused while kept In anclce bath. Wet weights of
each organ were taken. The lungs were pooled and frozen according to the
3 groups, controls, plasma volume expansion and plasma volume depletion.
Preparation of the Lung and Plasma Converting Enzymes
Each group of lung tissue was treated similarly but separately. The
converting enzyme was prepared according to the method of Dorer et al. (20)
for hog lung converting enzyme. In the purification steps where Dorer used
a pH of 7.0 for the sodium phosphate buffer, a pH 7.2 sodium buffer was
used Instead as a cooq>romlse between the methods of several Investigators
(17,20,53-55). Whole rabbit lungs were frozen and thawed twice and then
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prepared according to Dorer's method. The method Involved preparation of a
tissue homogenate, fractionation with ammonium sulfate, and Inactivation of
contaminating enzymes at pH 4.7.
In the control group, 97.2 g of Itmg tissue was used. Ihe tissue
was homogenized with 194.4 ml of cold 0.05 M sodium phosphate buffer (21/
kg tissue) pH 7.0. The homogenate was strained through gauze, frozen and
thawed twice, then centrifuged at 2000 xg for 2 hr. The resulting pre¬
cipitate was dissolved in 0.001 M sodium phosphate buffer, pH 7.0, and
dialyzed against 50 volumes of the same buffer for 18 hr with one change of
buffer after 4 hr. The dlalyzate, 84 ml, was re fractionated with 2.5 M
ammonium sulfate, stirred, and centrifuged. Hie precipitate was collected
and dissolved In 0.001 M sodium phosphate buffer, pH 7.0, and dialyzed
against the same buffer (50 volumes) for 18 hr. The dlalyzate was titrated
to pH 4.7 with 0.1 M phosphoric acid. The precipitate was removed by
centrifugation and the supernatant was dialyzed against a 0.01 M sodium
acetate buffer, pH 4.7 to give the final enzyme preparation.
In the volume expansion group, 64.1 g of lung tissue was used and
the tissue was homogenized with 128 ml of 0.05 M cold sodium phosphate
buffer, pH 7.0. The volimie of the supernatant after centrifugation at
2000 xg for two hr was 95 ml. For the voltjme.depletion group, 68.4 g of
tissue was homogenized with 136.8 ml of buffer after fdilch 110 ml of
supernatant was collected. The supernatant from the two groups of tissue
was treated as In the control group, yielding a final enzyme preparation
at pH 4.7.
The plasma converting enzyme activity was measured In the Initial
and final blood 8a9q>les collected. No further purification was made and
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this activity may be defined as the crude plasma converting enzyme
activity.
Converting Enzyme Assays
Enzyme and substrate were Incubated for 30 min at 37 C, in one ml
of 0.01 M sodium phosphate buffer containing 0.9% NaCl. The concentration
of the substrate, A I was 4 ng/ml for the plasma saiiq>les and 1.5 ng/ml for
the lung sanq>les. One ml of each sample was used. The reaction was
stopped by placing the test tubes In a boiling water bath for 5 min and
adding 30 mlcrollters of a solution containing 0.5 mH EDTA, 0.32 M
8-hydroxyquinoline sulfate, 0.05 M dlisopropyl fluorophosphate, and 0.2%
bacitracin. This inhibitory mixture was added to prevent any further con¬
version of A I into A II, and to prevent any further degradation of the
generated A II by the angiotenslnases.
The converting enzyme activity was measured as a function of the
disappearance of A I from the reaction mixture. The samples were assayed
according to the New England Nuclear RIA protocol for A I, which required
an 18-24 hr incubation period at 4 C with 125j ^ j antiserum specific
for A I. Samples were counted for 5 min each In a liquid scintillation
counter and the counts/mln (CFM) were converted to ng/ml/hr of A I. This
denoted the amount of A II formed after generation of the samples. Con¬
verting enzyme activity Is equal to ng/ml/hr of A I at 4 C minus the ng/
ml/hr of A I remaining at 37 C. All samples werd In duplicate and
were counted In sequence.
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Protein Determinations
Protein concentrations for each purification step were determined
according to the method of Lowry et al. (56) in order to determine the
specific activity of the enzyme preparations. Bovine serum albumin was
used as the standard. Measurements were made at a wavelength of 660 nm
on a Spectronic 20 (Bausch and Lomb).
CHAPTER IV
EXPERIMENTAL RESULTS
Part of the experimental statistical analysis was performed using an
Olivetti programmable mlcrocoiq>uter (Model P-652). The remaining data was
statistically analyzed at the Atlanta University Computer Center using an
IBM Computer (Model 1130). The results presented represent 5 animals per
group unless stated otherwise.
Blood Pressure Measurements
There were no significant changes in blood pressure in the 5 control
rabbits during the 20 min experimental period (Fig. 1). When 5 conscious
rabbits were hemorrhaged at a rate of 1.7 ml/mln for 15 min, a 247. decrease
in blood pressure from the control levels was seen. Figure 2 represents
blood pressure changes during plasma volume depletion (PVD). Plasma volume
expansion (PVE) at a rate of 1.7 ml/mln for 15 min caused a 17% Increase in
blood pressure in 5 conscious rabbits, as shown in Fig. 3.
Plasma Renin Activity
The results for plasma renin activity (PRA) represent one rabbit per
group. Figure 4 Illustrates the initial and final PRAs for the 3 groups,
controls, (PVE), and (PVS). Initially, PRA was highest in the control
animal (21.0 ng/ml/hr). The initial PRAs for the PVE and PVD groups did
not differ significantly, 14.8 ng/ml/hr and 16.0 ng/ml/hr, respectively.
Final PRAs dropped below initial levels in both the control and PVE rabbit,
with the greatest decrease in the PVE rabbit. Final PRA levels for the
control and PVE were 16.5 ng/ml/hr and 7.0 ng/ml/hr, respectively. In the
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Fig. 1. A graph of arterial blood pressure response of control rabbits
during the 20 min experimental period. The graph represents a








Fig. 2. A graph of arterial blood pressure response of normotenslve
rabbits during rapid plasma volume depletion. Hemorrhage rate
was 1.7 ml/mln for 15 min. The graph represents a tracing of the
actual physlograph recording from a representative experimental
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Fig. 3. A graph of arterial blood pressure response of normotenslve
rabbits during rapid plasma volume expansion. Infusion rate was
1.7 ml/mln for 15 min. Ihe graph represents a tracing of the
actual physlograph recording from a representative experimental
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Fig. A. A graph of plasma renin activity (PBA) in normotensive rabbits
during rapid plasma volume expansion and rapid plasma volume
depletion. N » 1 for each group.
C Control
r yc Plasma volume depletion
PVE Plasma volume expansion
I 1 Initial PRA
7/ A Final PRA
PVD PVE
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FVD animal PRA Increased after plasma voltnne depletion from the Initial
level of 14.8 ng/ml/hr to the final PRA of 20 ng/ml/hr.
Plasma Converting Enzyme Activity
The results for plasma converting enzyme activity (CEA) are shown In
Fig. 5. Initially, CEA was highest In the PVE group (5.81 + 3.01 ng/ml/
hr), with similar levels seen In the control and PVD groups, 5.12 + 2.67
ng/ml/hr and 4.67 + 2.09 ng/ml/hr, respectively. A decrease In CEA was
seen In the final samples from all 3 groups, with the greatest decrease
from the Initial levels seen In the PVD group. Final CEA levels were,
controls; 3.82 + 2.79 ng/ml/hr, PVD; 1.98 + 0.82 ng/ml/hr, and PVE; 3.03 +
1.99 ng/ml/hr. Table 1 Is a sumnary of PRA and CEA, hematocrit values and
CEA specific activity. The hematocrit decreased In both experimental
groups from the control value of 42.96 + 2,5. The hematocrits were 32,6 +
2.88 for the PVE group and 36.0 + 5.2 for the PVD group.
Lung Converting Enzyme Activity
The results from the partial purification of lung converting enzyme
are suxnnarlzed In Fig. 6. There were 4 purification steps which are de¬
noted by the letters. A, B, C, and D. A represents the crude extract or
lung homogenate; B the 3.0 M ammonium sulfate precipitation; C the 2.5 M
ammonium sulfate precipitation; and D the pH 4.7 enzyme preparation. In
all groups, an Increase In CEA was seen with further purification. The
greatest Increase In activity was seen In the final enzyme preparation (D)
for the FVD group. The control group showed the lowest Increase In CEA
with purification.
Fig. 5. A graph of plasma converting enzyme activity (CEA) in normotensive
rabbits during rapid plasma volume expansion and rapid plasma
volinne depletion. N » 5 for each group.
i Controls
P Plasilaa volume depletion
p E Plasma volume expansion
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5 36.00 + 5.22 14.8 20.0 4.67 + 2.09 1.98 + 0.82 34.09 14.45
a ■> values represent 1 rabbit per group
b » CEA/mg protein
c B jh SD >■ standard deviation of the mean
All values represent the mean for the nunber (N) of rabbits per group
Fig. 6. A graph of converting enzyme activity in the stepwise purification
of rabbit lung converting enzyme.
O Controls
^ Plasma volume expansion
ik Plasma volume depletion
A Lung extract
B 3.0 M ammonium sulfate precipitation
C 2.5 M ammonium sulfate precipitation
D pH 4.7 supernatant solution
CONVERTINGENZYME ACTIVITY (ng/ml/hr)
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Tables 2, 3, and 4 sunmarlze the purification procedures for the 3
groups. The specific activity Increased In all groups with Increased
purification. The FVD group showed the greatest increase in specific
activity. The Increase In specific activity with simultaneous Increases
In CEA revealed a direct relationship between the two measurements.
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A Lung extract 0.18 1.07
B 3.0 M ammonium sulfate
precipitation 0.6 4.55
C 2.5 M ammonium sulfate
precipitation 1.05 37.50
D pH 4.7 supernantant solution 1.40 70.00
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A Lung extract 0.42 2.50
B 3.0 M ammonium sulfate
precipitation 0.72 5.45
C 2.5 M ammonium sulfate
precipitation 1.68 76.36
D pH 4.7 supernatant solution 1.83 91.50
24






A Lung extract 0.38 2.25
B 3.0 M ammonium sulfate
precipitation 1.35 10.23
C 2.5 M amnonlum sulfate
precipitation 1.53 54.64
D pH 4.7 supernatant solution 3.24 162.00
CHAPTER V
DISCUSSION
The renln-anglotensln system is important in the maintenance of
arterial blood pressure (57,58). We have, therefore, tried to evaluate the
components of the renin-angiotensin system and their effects on blood
pressure regulation. It has been well documented that most of the conver¬
sion of A I in vivo occurs in the lungs (9,28-31), and that the pulmonary
arteries contain more converting enzyme (CE) than do other vessels (52).
Studies in situ have shown that at low concentrations of A I, 80% was con¬
verted to A II in the lungs, but if the asiount of A I injected was
increased, conversion dropped to 30%, indicating saturation of the con¬
verting process (31). The main area of disagreement, however, was the
degree of conversion of A I to A II in one transit throug)i the pulmonary
circulation.
Ilie primary objective of this investigation was to measure con¬
verting enzyme activity (CEA) in the lungs and plasma of nonnotenslve
rabbits. Secondly, our purpose was to measure other factors which are
known to assist the cardiovascular system in the process of autoregulation,
such as blood pressure changes and plasma renin activity (PRA). Thirdly,
we wanted to examine the effects of rapid plasma volume expansion (PVE)
and rapid plasma volume depletion (PVD) on blood pressure and the com¬
ponents of the renin-angiotensin system.
'Hie results obtained for blood pressure changes and plasma renin
levels confirmed the work done previously in our laboratory (59) on PRA in
rabbits on hlgjh, low, and control salt diets subjected to rapid PVE and
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rapid PVD. In both investigations, plasma volume expansion caused an in¬
crease in arterial pressure with a simultaneous decrease in PSA. Arterial
pressure decreased during FVD while FRA increased significantly. The ini¬
tial and final PSAs in the present investigation were higher than those of
the previous study (59) but similar results were obtained. These results
agree with the work of others on plasma renin activity in relation to blood
voliime alterations (11,60-62).
Ihe studies on plasma (CEA) during rapid FVE and PVD revealed that
the blood volume alterations had no significant effect on CEA. Ihere was
no significant difference in the initial and final levels in all groups
(p .05; in all cases). CEA has been measured in normotenslve and hyper¬
tensive rats (17) and no significant difference was seen between the two
groups. Our findings in rabbits agree with these observations. Althou^
the A 1 converting enzyme was discovered in horse blood (2), it has been •
shown that most of the circulating A I is converted in the lung (7,28). It
has been suggested that the lungs m^ be the origin of the plasma CE (39).
Our results showed no direct correlation between PRA and plasma CEA.
Our attempt to partially purify lung CE was successful in that the
activity of the enzyme Increased with the degree of purity in all groups.
The final enzyme preparations caused a significant Increase in specific
activity. A 65-fold Increase was seen in the control group, with in¬
creases of 37-fold in the FVE group and a 72-fold increase in the FVD
group. Since the FVD group showed the highest increase in CEA, it may be
speculated that during rapid PVD, the degree of conversion of A I to A II
is enhanced to compensate for the decreases in arterial pressure seen
during hemorrhage. PRA was also seen to Increase during volume depletion.
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An Increase In the levels of circulating A 1 might then be a stimulus for
Increased conversion of A I to A II, by the CE. It has been found that the
formation of A II is Increased when the blood pressure falls (63) or the
extracellular fluid volume is reduced, and also that A II helps to maintain
blood pressure. Our results confirm those of other investigators since we
have shown that A I can be converted to A II by enzyme preparations from
plasma and from lung. The low levels of conversion in the plasma are in
agreement with the work of others and the CEA of the lung supports the view
that the lung is the major source of the converting enzyme. A direct
correlation was seen between the CEA of the lung and PRA levels during
periods of rapid plasma volume depletion.
CHAPTER VI
SUMMARY
1. The assay procedure for converting enz3nne activity (CEA) was validated
by a cosqparatlve analysis of plasma and lung converting enzyme in
normotenslve rabbits during periods of rapid plasma volxnne expansion
(FVE) and rapid plasma volume depletion (PVD).
2. PVE caused a 17% increase in blood pressure with a simultaneous
decrease In plasma renin activity (PRA).
3. PVD resulted In a 24% decrease In blood pressure \diile PRA Increased
significantly.
4. PVE and PVD had no significant effect on plasma CEA.
5. Partial purification of the lung converting enzyme resulted in an
Increase In the specific activity of both the control and the experi*
mental groups.
6. The PVD group showed the greatest Increase In specific activity while
the PVE had the lowest Increase.
7. No direct correlations between PRA and plasma CEA were seen, but limg
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